KIMBERLEY RUBINO: Open Payments
NPI 1760962328 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,014 in 93 payments from 20 companies in 2025. Trend: 2023 $11,276 · 2024 $5,873 · 2025 $5,014
Speaker / faculty: $2,750Food & beverage: $2,172Travel & lodging: $92
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $3,178 |
| Janssen Pharmaceuticals, Inc | 9 | $307 |
| Axsome Therapeutics, Inc. | 4 | $187 |
| Corium, LLC | 9 | $176 |
| Otsuka America Pharmaceutical, Inc. | 8 | $167 |
| Alkermes, Inc. | 7 | $149 |
| Vanda Pharmaceuticals Inc. | 6 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $101 |
| Teva Pharmaceuticals USA, Inc. | 4 | $101 |
Products named: VRAYLAR, SPRAVATO, Auvelity, Azstarys, ARISTADA, REXULTI, HETLIOZ, CAPLYTA.
Industry payments across NY — which companies pay providers there.
